NCT06810245View on ClinicalTrials.gov

Study of PIPE-791 for Subjects with Chronic Osteoarthritis Pain or Chronic Low Back Pain

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 4, 2025

Primary Completion Date

December 15, 2025

Study Completion Date

February 15, 2026

Conditions
Chronic Osteoarthritis PainChronic Low Back Pain
Interventions
DRUG

PIPE-791

PIPE-791 tablet, taken once daily for 4 weeks

DRUG

Placebo

Placebo tablet, taken once daily for 4 weeks

Trial Locations (5)

10530

RECRUITING

Drug Trials America, Hartsdale

16635

RECRUITING

Altoona Center of Clinical Research, Duncansville

30060

RECRUITING

Drug Studies America, Marietta

84107

RECRUITING

JBR Clinical Research, Salt Lake City

85053

RECRUITING

Arizona Research Center, Phoenix

Sponsors
All Listed Sponsors
lead

Contineum Therapeutics

INDUSTRY

NCT06810245 - Study of PIPE-791 for Subjects with Chronic Osteoarthritis Pain or Chronic Low Back Pain | Biotech Hunter | Biotech Hunter